SEDI Insider filing browser
Filter by Company
×
Filter by $CAD Amount
×
Filter by Filing Type
Filter by Insider
×
 
Date Issuer Insider Transaction Amount New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
Filed 2025-04-09 15:38
Tx date 2025-02-18 		$APS
Aptose Biosciences Inc. 		Rice, William Glenn
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Warrants
37 - Stock split or consolidation
-48,333 vol 		1,667
Filed 2025-04-09 15:37
Tx date 2025-02-18 		$APS
Aptose Biosciences Inc. 		Rice, William Glenn
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
37 - Stock split or consolidation
-420,373 vol 		14,489
Filed 2025-04-09 15:36
Tx date 2025-02-18 		$APS
Aptose Biosciences Inc. 		Rice, William Glenn
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
37 - Stock split or consolidation
-129,743 vol 		4,473
Filed 2025-01-13 14:24
Tx date 2024-06-15 		$APS
Aptose Biosciences Inc. 		Rice, William Glenn
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
52 - Expiration of options
-26,408 vol 		434,862
Filed 2025-01-13 14:22
Tx date 2024-04-10 		$APS
Aptose Biosciences Inc. 		Rice, William Glenn
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
52 - Expiration of options
-9,333 vol 		461,270
Filed 2025-01-13 14:21
Tx date 2024-01-29 		$APS
Aptose Biosciences Inc. 		Rice, William Glenn
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
52 - Expiration of options
-352 vol 		400,603
Filed 2025-01-13 14:20
Tx date 2023-12-10 		$APS
Aptose Biosciences Inc. 		Rice, William Glenn
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
52 - Expiration of options
-4,342 vol 		400,955
Filed 2025-01-13 14:18
Tx date 2023-10-27 		$APS
Aptose Biosciences Inc. 		Rice, William Glenn
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
52 - Expiration of options
-2,361 vol 		405,297
Filed 2024-11-27 14:31
Tx date 2024-11-25 		$APS
Aptose Biosciences Inc. 		Rice, William Glenn
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Warrants
15 - Acquisition or disposition under a prospectus
+50,000 vol 		50,000
Filed 2024-11-27 14:25
Tx date 2013-10-28 		$APS
Aptose Biosciences Inc. 		Rice, William Glenn
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Warrants
00 - Opening Balance-Initial SEDI Report
Filed 2024-11-27 14:23
Tx date 2024-11-25 		$APS
Aptose Biosciences Inc. 		Rice, William Glenn
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
15 - Acquisition or disposition under a prospectus 		$20,000
+100,000 vol
$0.20 each 		134,216
Filed 2024-02-08 09:52
Tx date 2024-02-05 		$APS
Aptose Biosciences Inc. 		Rice, William Glenn
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
+70,000 vol 		477,658
Filed 2023-08-11 11:02
Tx date 2023-05-24 		$APS
Aptose Biosciences Inc. 		Rice, William Glenn
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
37 - Stock split or consolidation
-5,707,305 vol 		407,658
Filed 2023-08-11 10:58
Tx date 2023-05-24 		$APS
Aptose Biosciences Inc. 		Rice, William Glenn
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
37 - Stock split or consolidation
-479,036 vol 		34,216
Filed 2023-01-24 15:30
Tx date 2023-01-19 		$APS
Aptose Biosciences Inc. 		Rice, William Glenn
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights
+150,000 vol 		513,252
Filed 2023-01-24 15:29
Tx date 2023-01-19 		$APS
Aptose Biosciences Inc. 		Rice, William Glenn
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Restricted Share Units
57 - Exercise of rights
-150,000 vol 		0
Filed 2023-01-24 15:28
Tx date 2023-01-19 		$APS
Aptose Biosciences Inc. 		Rice, William Glenn
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Restricted Share Units
56 - Grant of rights
+150,000 vol 		150,000
Filed 2023-01-24 15:28
Tx date 2023-01-19 		$APS
Aptose Biosciences Inc. 		Rice, William Glenn
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
+400,000 vol 		6,114,963
Filed 2022-09-22 09:53
Tx date 2022-09-19 		$APS
Aptose Biosciences Inc. 		Rice, William Glenn
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$2,939
+4,300 vol
$0.68 each 		363,252
Filed 2022-09-22 09:52
Tx date 2022-09-19 		$APS
Aptose Biosciences Inc. 		Rice, William Glenn
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$3,895
+5,700 vol
$0.68 each 		358,952